1 / 22

Control of Microbial Growth

Control of Microbial Growth. Tim Ho University of Alberta, Canada * The materials are mostly based on Dr. Brian Lanoil’s Microb 265. Part II. Objectives. Physical agents Mechanical removal methods Chemical agents. Know 3 methods of microbial control

denver
Download Presentation

Control of Microbial Growth

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Control of Microbial Growth Tim Ho University of Alberta, Canada * The materials are mostly based on Dr. Brian Lanoil’s Microb 265 Part II tim3@ualberta.ca

  2. Objectives • Physical agents • Mechanical removal methods • Chemical agents tim3@ualberta.ca Know 3 methods of microbial control Know the strategies on how drugs control the growth of microorganisms. Understand how do bacteria become resistant to antibiotics.

  3. Characteristics of antimicrobial drugs: • With minimal side effects • Therapeutic dose: the amount of drug required for treatment or the desired effect. • Broad spectrum activity: against a wide variety of pathogens or do not know the specific bacteria that want to target. • Chemotherapeutic agents can be synthetic or semi-synthetic. tim3@ualberta.ca

  4. Dilution Susceptibility test • Each test tube containing different concentrations of drug - MIC: minimum inhibitory concentration - MLC: minimum lethal concentration Low [drug] high [drug] tim3@ualberta.ca + + + + + + + - - - 4

  5. Disk diffusion test • Kirby-Bauer method • Drug diffuses from disk into agar, establishing concentration gradient • Measure the diameter of clear zone (no growth) around disks -> determine MIC and MLC tim3@ualberta.ca Large clear zone = sensitive No or small clear zone = resistant 5 Image:http://www.biotopics.co.uk/microbes/penici.html

  6. Disk diffusion test tim3@ualberta.ca Image:http://www.biotopics.co.uk/microbes/penici.html

  7. How different types of antibiotics affect cell functions tim3@ualberta.ca 7

  8. Folic acid synthesis inhibitors tim3@ualberta.ca 8

  9. Folic acid synthesis inhibitors • Sulfanilamide: • Competitive inhibitor of PABA • [PABA] ↑= rate of folic acid biosynthesis ↓ Image: Fdardel, 2011 tim3@ualberta.ca 9

  10. DNA gyrase inhibitors tim3@ualberta.ca 10

  11. DNA gyrase inhibitors DNA gyrase: the enzyme that introduces negative supercoils into DNA Ciprofloxacin Image: Drug Reference - Encyclopedia • Quinolones: • inhibit bacterial DNA gyrase • effective against G- urinary tract infections and respiratory infections • (eg. Bacillus anthracis) • [PABA] ↑= rate of folic acid biosynthesis ↓ tim3@ualberta.ca 11

  12. RNA synthesis inhibitors tim3@ualberta.ca 12

  13. RNA synthesis inhibitors • Rifamycin/ Rifampin: • block transcription by binding RNA polymerase • Not selectively toxic • → Prokaryotes and eukaryotes synthesize nucleic acids in pretty much the same way • [PABA] ↑= rate of folic acid biosynthesis ↓ tim3@ualberta.ca 13

  14. Cell wall synthesis inhibitors • Ampicillin is protected from lactamases by co-treatment with clavulanic acid • WHY: ß-lactamases have higher binding affinity for clavulanic acid than ampicillin tim3@ualberta.ca 14 Image: Dengler et al.BMC Microbiology 2011 11:16   doi:10.1186/1471-2180-11-16

  15. Cell wall synthesis inhibitors G + bacteria are more susceptible to ß-lactam antibiotics!! Activity is blocked by binding to transpeptidases (transpeptidase) tim3@ualberta.ca It breaks ß-lactam rings: antibiotic resistance - G+ cells: ß-lactamases are located on outside surface G- cells: ß-lactamases are in periplasmic space 15 Image: Insilico Genomics Lab Technologies. http://insilicogenomics.in/penicillin.asp

  16. Cell wall synthesis inhibitors blocks dephosphorylation of bactoprenol phosphate blocks transpeptidization tim3@ualberta.ca blocks D-Ala peptidization 16 Image: Dengler et al.BMC Microbiology 2011 11:16   doi:10.1186/1471-2180-11-16

  17. Protein synthesis inhibitors tim3@ualberta.ca 17

  18. Protein synthesis inhibitors • Macrolides: • Binding to the large subunit ribosome • Tetracyclines: • - First broad-spectrum antibiotics • Blocking tRNA attachment to ribosome • effective against G- and G+ cells tim3@ualberta.ca • Aminoglycosides: • Binding to the small subunit ribosome • effective against G- cells 18

  19. Cytoplasmic membrane inhibitors tim3@ualberta.ca 19

  20. Cytoplasmic membrane inhibitors • Daptomycin: • Cyclic lipopeptide • Makes pore on cytoplasmic membrane • Resistance from changes in cell membrane structure • Primarily targets G+ cells (G- cells have extra outer membrane: protection) tim3@ualberta.ca 20

  21. Anti-fungal Drugs • Fungal infections are difficult to treat • - host and pathogen have biological similarity • → drug can harm host at the same time • Target against chitin (fungal cell wall) mostly • - animals (host) don’t have chitin • Nystatin: first discovered antifungal antibiotic in 1949 by Hazen and Brown • Superficial mycoses • - Infections of outer layers of skin • - Treatment (drugs): Miconazole, Nystatin, and Griseofulvin • - Minimizes toxic systemic side effects (e.g. liver damage) tim3@ualberta.ca 21

  22. AntiviralDrugs • Many drugs are still in development stage • Mainly target against either RNA or DNA synthesis of viral pathogen • - Structural analogs of purine or pyrimidine bases • - difficulties: viruses use metabolic machinery of the host • Protease inhibitors: against virus-specific enzymes • Interferons: stimulate production of host anti-viral proteins tim3@ualberta.ca 22

More Related